Inventor
OHTOMO TOSHIHIKO
JP26 patents
⚠️ This page may combine multiple inventors who share the name “OHTOMO TOSHIHIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHUGAI PHARMACEUTICAL CO LTD
18 patentsUS6989244B1Jan 24, 2006
Method for screening compounds inhibiting signal transduction through inflammatory cytokines
CHUGAI PHARMACEUTICAL CO LTD71 citations95
US6214973B1Apr 10, 2001
Reshaped human antibody to human medulloblastoma cells
CHUGAI PHARMACEUTICAL CO LTD26 citations92
US6699974B2Mar 2, 2004
Reshaped human anti-HM 1.24 antibody
CHUGAI PHARMACEUTICAL CO LTD32 citations91
US6551840B2Apr 22, 2003
Method of screening TGF-β-inhibiting substances
CHUGAI PHARMACEUTICAL CO LTD16 citations84
US8034903B2Oct 11, 2011
Degraded TPO agonist antibody
CHUGAI PHARMACEUTICAL CO LTD8 citations83
US10782300B2Sep 22, 2020
GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy
CHUGAI PHARMACEUTICAL CO LTD4 citations72
US11767362B1Sep 26, 2023
Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies
CHUGAI PHARMACEUTICAL CO LTD2 citations71
US11376326B2Jul 5, 2022
GPC3-targeting therapeutic agent which is administered to patient for whom the GPC3-targeting therapeutic agent is effective
CHUGAI PHARMACEUTICAL CO LTD2 citations71
US6610485B1Aug 26, 2003
Methods for isolating a cDNA encoding a membrane-bound protein
CHUGAI PHARMACEUTICAL CO LTD8 citations71
US6451617B1Sep 17, 2002
Method of screening TGF-β inhibitory substances
CHUGAI PHARMACEUTICAL CO LTD4 citations62
US6908750B2Jun 21, 2005
Gene encoding HM1.24 antigen protein and promoter thereof
CHUGAI PHARMACEUTICAL CO LTD4 citations61
US6613546B1Sep 2, 2003
Gene encoding HM1.24 antigen protein and promoter thereof
CHUGAI PHARMACEUTICAL CO LTD4 citations61
US7563599B2Jul 21, 2009
Reshaped human antibody to human medulloblastoma cells
CHUGAI PHARMACEUTICAL CO LTD0 citations52
US7666610B2Feb 23, 2010
Expressing transporters on viral envelopes
CHUGAI PHARMACEUTICAL CO LTD0 citations49
US7338797B2Mar 4, 2008
Compositions for isolating a cDNA encoding a membrane-bound protein
CHUGAI PHARMACEUTICAL CO LTD0 citations49
US10451627B2Oct 22, 2019
Method for assaying soluble GPC3 protein
CHUGAI PHARMACEUTICAL CO LTD0 citations47
US7067297B2Jun 27, 2006
Mannosyltransferase polypeptides and polynucleotides encoding them and methods for making and using them
CHUGAI PHARMACEUTICAL CO LTD0 citations46
US11760807B2Sep 19, 2023
GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy
CHUGAI PHARMACEUTICAL CO LTD0 citations45
ABURATANI HIROYUKI
5 patentsUS7812128B2Oct 12, 2010
Gene overexpressed in cancer
ABURATANI HIROYUKI3 citations58
US9644029B2May 9, 2017
Cancer diagnosis and treatment of cancer using anti-ROBO1 antibody
ABURATANI HIROYUKI0 citations49
US9376475B2Jun 28, 2016
Gene overexpressed in cancer
ABURATANI HIROYUKI0 citations48
US9434775B2Sep 6, 2016
Gene overexpressed in cancer
ABURATANI HIROYUKI0 citations47
US8940488B2Jan 27, 2015
Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
ABURATANI HIROYUKI0 citations37